News

PELOPaper: Insights into Infant Formula and Immune Responses

A recent study published in the European Journal of Nutrition by Hedegger, Hommel, Schaubeck et al. explores the impact of different infant formulas on intestinal immune responses.

PELOPaper: Advanced Skin Research with a Psoriasis Skin Equivalent Model

A recent study introduces a bilayered skin equivalent that closely mimics psoriasis. This innovative model bridges a critical gap in preclinical studies, offering unparalleled insights into disease mechanisms and potential therapeutic interventions.

PELOPaper: Insights into Liver Endothelial Cell Function in Cirrhosis with PELOBiotech Products

A study published in Cellular and Molecular Gastroenterology and Hepatology highlights advances in understanding liver sinusoidal endothelial cells (LSECs) in cirrhosis, thanks to single-cell transcriptomics.

PELOPaper: Cellovations Lung Fibroblasts to Create 3D Vasculature-on-Chip Models

A recent study published in Advanced Materials Technologies highlights Cellovations products in advancing tissue engineering and microfluidic models.

2024 Trade Show Season Concludes with Success at MuSkITYR Symposium

We are pleased to announce the successful conclusion of our 2024 trade show engagements, culminating at the MuSkITYR Symposium in Vienna. Our CEO and CSO, Dr. Lothar Steeb, had an engaging and productive experience, and we look forward to connecting with everyone again next year.

iPSC-Derived Cardiomyocytes: Advancing Cardiac Research & Drug Discovery

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are transforming cardiac research and drug discovery. Pioneered by Takahashi and Yamanaka, these cells are crucial for disease modeling and drug safety. Companies like NEXEL lead with innovations like the Cardiosight -S platform. Despite challenges, advancements in hiPSC-CM maturity and organ-on-a-chip integration promise breakthroughs in personalized medicine.